Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2021

01-12-2021 | Obesity | Research

Waist to height ratio is associated with an increased risk of mortality in Chinese patients with heart failure with preserved ejection fraction

Authors: Jianqiao Chen, Man Li, Benchuan Hao, Yulun Cai, Huiying Li, Wenli Zhou, Yujian Song, Shiqi Wang, Hongbin Liu

Published in: BMC Cardiovascular Disorders | Issue 1/2021

Login to get access

Abstract

Background

Abdominal obesity as a predominant comorbidity has played a key role in the incidence and worsening of heart failure with preserved ejection fraction (HFpEF), and waist-to-height ratio (WHtR) behaves better than waist circumference or body mass index in evaluating abdominal obesity. While the association between WHtR and all-cause death in Chinese patients with HFpEF remains unclear.

Methods

Patients with stable HFpEF (N = 2041) who presented to our hospital from January 2008 to July 2019 were divided into low-WHtR (< 0.5, N = 378) and high-WHtR (≥ 0.5, N = 1663). Multivariable Cox proportional-hazard models were used to examine the association of WHtR with all-cause death.

Results

The average age was 76.63 ± 11.44 years, and the mean follow-up was 4.53 years. During follow-up, 185 patients (9.06%) reached the primary outcome of all-cause death. As for the secondary outcome, 79 patients (3.87%) experienced cardiovascular death, 106 (5.19%) had non-cardiovascular death, and 94 (4.61%) had heart failure rehospitalization. After multivariable adjustment, a higher WHtR was significantly associated with the increased risks of all-cause death [adjusted hazard ratios (HR) 1.91, 95% confidence interval (CI) 1.06–3.45, p = 0.032], cardiovascular death (adjusted HR 2.58; 95% CI 1.01–6.67, p = 0.048), and HF rehospitalization (adjusted HR 3.04; 95% CI 1.26–7.31, p = 0.013).

Conclusions

Higher WHtR is an independent risk factor for all-cause death in Chinese patients with HFpEF.
Appendix
Available only for authorised users
Literature
1.
go back to reference Steinberg BA, Zhao X, Heidenreich PA, et al. Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes. Circulation. 2012;126(1):65–75.CrossRefPubMed Steinberg BA, Zhao X, Heidenreich PA, et al. Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes. Circulation. 2012;126(1):65–75.CrossRefPubMed
3.
4.
go back to reference Paulus WJ, Tschöpe C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol. 2013;62(4):263–71.PubMedCrossRef Paulus WJ, Tschöpe C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol. 2013;62(4):263–71.PubMedCrossRef
5.
go back to reference Taube A, Schlich R, Sell H, et al. Inflammation and metabolic dysfunction: links to cardiovascular diseases. Am J Physiol Heart Circ Physiol. 2012;302(11):H2148.PubMedCrossRef Taube A, Schlich R, Sell H, et al. Inflammation and metabolic dysfunction: links to cardiovascular diseases. Am J Physiol Heart Circ Physiol. 2012;302(11):H2148.PubMedCrossRef
6.
go back to reference Selvaraj S, Kim J, Ansari BA, et al. Body composition, natriuretic peptides, and adverse outcomes in heart failure with preserved and reduced ejection fraction. JACC Cardiovasc Imaging. 2021;14(1):203–15.PubMedCrossRef Selvaraj S, Kim J, Ansari BA, et al. Body composition, natriuretic peptides, and adverse outcomes in heart failure with preserved and reduced ejection fraction. JACC Cardiovasc Imaging. 2021;14(1):203–15.PubMedCrossRef
7.
go back to reference Rao VN, Fudim M, Mentz RJ, et al. Regional adiposity and heart failure with preserved ejection fraction. Eur J Heart Fail. 2020;22(9):1540–50.PubMedCrossRef Rao VN, Fudim M, Mentz RJ, et al. Regional adiposity and heart failure with preserved ejection fraction. Eur J Heart Fail. 2020;22(9):1540–50.PubMedCrossRef
8.
go back to reference Tsujimoto T, Kajio H. Abdominal obesity is associated with an increased risk of all-cause mortality in patients with HFpEF. J Am Coll Cardiol. 2017;70(22):2739–49.PubMedCrossRef Tsujimoto T, Kajio H. Abdominal obesity is associated with an increased risk of all-cause mortality in patients with HFpEF. J Am Coll Cardiol. 2017;70(22):2739–49.PubMedCrossRef
9.
go back to reference Haykowsky MJ, Nicklas BJ, Brubaker PH, et al. Regional adipose distribution and its relationship to exercise intolerance in older obese patients who have heart failure with preserved ejection fraction. JACC Heart Fail. 2018;6(8):640–9.PubMedPubMedCentralCrossRef Haykowsky MJ, Nicklas BJ, Brubaker PH, et al. Regional adipose distribution and its relationship to exercise intolerance in older obese patients who have heart failure with preserved ejection fraction. JACC Heart Fail. 2018;6(8):640–9.PubMedPubMedCentralCrossRef
10.
go back to reference Garvey WT, Garber AJ, Mechanick JI, et al. American association of clinical endocrinologists and American college of endocrinology position statement on the 2014 advanced framework for a new diagnosis of obesity as a chronic disease. Endocr Pract. 2014. Garvey WT, Garber AJ, Mechanick JI, et al. American association of clinical endocrinologists and American college of endocrinology position statement on the 2014 advanced framework for a new diagnosis of obesity as a chronic disease. Endocr Pract. 2014.
11.
go back to reference Heymsfield SB, Peterson CM, Thomas DM, et al. Why are there race/ethnic differences in adult body mass index-adiposity relationships? A quantitative critical review. Obes Rev. 2016;17(3):262–75.PubMedCrossRef Heymsfield SB, Peterson CM, Thomas DM, et al. Why are there race/ethnic differences in adult body mass index-adiposity relationships? A quantitative critical review. Obes Rev. 2016;17(3):262–75.PubMedCrossRef
12.
go back to reference Zeng Q, He Y, Dong S, et al. Optimal cut-off values of BMI, waist circumference and waist:height ratio for defining obesity in Chinese adults. Br J Nutr. 2014;112:1735–44.PubMedCrossRef Zeng Q, He Y, Dong S, et al. Optimal cut-off values of BMI, waist circumference and waist:height ratio for defining obesity in Chinese adults. Br J Nutr. 2014;112:1735–44.PubMedCrossRef
13.
go back to reference Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129–200.CrossRefPubMed Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129–200.CrossRefPubMed
14.
go back to reference Shao J, Yu L, Shen X, et al. Waist-to-height ratio, an optimal predictor for obesity and metabolic syndrome in Chinese adults. J Nutr Health Aging. 2010;14(9):782–5.PubMedCrossRef Shao J, Yu L, Shen X, et al. Waist-to-height ratio, an optimal predictor for obesity and metabolic syndrome in Chinese adults. J Nutr Health Aging. 2010;14(9):782–5.PubMedCrossRef
15.
go back to reference Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev. 2012;13(3):275–86.PubMedCrossRef Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev. 2012;13(3):275–86.PubMedCrossRef
16.
go back to reference Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRefPubMed Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRefPubMed
17.
go back to reference Pieske B, Tschöpe C, Boer RAD, et al. How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J. 2019;40(40):3297–317.PubMedCrossRef Pieske B, Tschöpe C, Boer RAD, et al. How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J. 2019;40(40):3297–317.PubMedCrossRef
18.
go back to reference Nagueh S, Smiseth O, Appleton C, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016;17(12):1321–60.PubMedCrossRef Nagueh S, Smiseth O, Appleton C, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016;17(12):1321–60.PubMedCrossRef
19.
go back to reference Dunlay SM, Roger VRL, Redfield MM. Epidemiology of heart failure with preserved ejection fraction. Nat Rev Cardiol. 2017;14(10):591–602.PubMedCrossRef Dunlay SM, Roger VRL, Redfield MM. Epidemiology of heart failure with preserved ejection fraction. Nat Rev Cardiol. 2017;14(10):591–602.PubMedCrossRef
21.
go back to reference Association OGoESoCM. An Experts Consensus for the prevention and treatment of Chinese adult obesity. Chin J Endocrinol Metab. 2011;027(009):711–717. Association OGoESoCM. An Experts Consensus for the prevention and treatment of Chinese adult obesity. Chin J Endocrinol Metab. 2011;027(009):711–717.
22.
go back to reference Yong W, Cunchuan W, Sunghong Z, et al. Guidelines for surgical management of obesity and type 2 diabetes in China (2019). Chin J Pract Surg. 2019;39(04):6–11. Yong W, Cunchuan W, Sunghong Z, et al. Guidelines for surgical management of obesity and type 2 diabetes in China (2019). Chin J Pract Surg. 2019;39(04):6–11.
23.
go back to reference Rao G, Powell-Wiley TM, Ancheta I, et al. Identification of obesity and cardiovascular risk in ethnically and racially diverse populations: a scientific statement from the American Heart Association. Circulation. 2015;132(5):457.PubMedCrossRef Rao G, Powell-Wiley TM, Ancheta I, et al. Identification of obesity and cardiovascular risk in ethnically and racially diverse populations: a scientific statement from the American Heart Association. Circulation. 2015;132(5):457.PubMedCrossRef
24.
go back to reference Haass M, Kitzman DW, Anand IS, et al. Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial. Circ Heart Fail. 2011;4(3):324–31.PubMedPubMedCentralCrossRef Haass M, Kitzman DW, Anand IS, et al. Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial. Circ Heart Fail. 2011;4(3):324–31.PubMedPubMedCentralCrossRef
25.
go back to reference Tisminetzky M, Gurwitz JH, Fan D, et al. Multimorbidity burden and adverse outcomes in a community-based cohort of adults with heart failure. J Am Geriatr Soc. 2018;66:2305–13.PubMedPubMedCentralCrossRef Tisminetzky M, Gurwitz JH, Fan D, et al. Multimorbidity burden and adverse outcomes in a community-based cohort of adults with heart failure. J Am Geriatr Soc. 2018;66:2305–13.PubMedPubMedCentralCrossRef
26.
go back to reference Deursen VMV, Urso R, Laroche C, et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey. Eur J Heart Fail. 2014;16(1):103–11.CrossRefPubMed Deursen VMV, Urso R, Laroche C, et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey. Eur J Heart Fail. 2014;16(1):103–11.CrossRefPubMed
27.
go back to reference Conde-Martela A, Hernández-Menesesa M. Prevalence and prognostic meaning of comorbidity in heart failure. Rev Clin Esp. 2016;216(4):222–8. Conde-Martela A, Hernández-Menesesa M. Prevalence and prognostic meaning of comorbidity in heart failure. Rev Clin Esp. 2016;216(4):222–8.
28.
go back to reference Ruiz-Laiglesia FJ, Sánchez-Marteles M, Pérez-Calvo JI, et al. Comorbidity in heart failure. Results of the Spanish RICA Registry. QJM. 2014;107(12):989–94.PubMedCrossRef Ruiz-Laiglesia FJ, Sánchez-Marteles M, Pérez-Calvo JI, et al. Comorbidity in heart failure. Results of the Spanish RICA Registry. QJM. 2014;107(12):989–94.PubMedCrossRef
29.
go back to reference Parikh KS, Sharma K, Pharmd MF, et al. Heart failure with preserved ejection fraction expert panel report: current controversies and implications for clinical trials. JACC Heart Fail. 2018;6(8):619–32.PubMedCrossRef Parikh KS, Sharma K, Pharmd MF, et al. Heart failure with preserved ejection fraction expert panel report: current controversies and implications for clinical trials. JACC Heart Fail. 2018;6(8):619–32.PubMedCrossRef
30.
go back to reference Lavie CJ, Alpert MA, Arena R, et al. Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure. JACC Heart Fail. 2013;1(2):93–102.CrossRefPubMed Lavie CJ, Alpert MA, Arena R, et al. Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure. JACC Heart Fail. 2013;1(2):93–102.CrossRefPubMed
31.
go back to reference Maisel AS, Daniels LB. Breathing not properly 10 years later: what we have learned and what we still need to learn. J Am Coll Cardiol. 2012;60(4):277–82.PubMedCrossRef Maisel AS, Daniels LB. Breathing not properly 10 years later: what we have learned and what we still need to learn. J Am Coll Cardiol. 2012;60(4):277–82.PubMedCrossRef
32.
go back to reference Owan TE, Hodge DO, Herges RM, et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006;355(3):251–9.PubMedCrossRef Owan TE, Hodge DO, Herges RM, et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006;355(3):251–9.PubMedCrossRef
33.
go back to reference Shah SJ, Kitzman DW, Borlaug BA, et al. Phenotype-specific treatment of heart failure with preserved ejection fraction: a multiorgan roadmap. Circulation. 2016;134(1):73–90.PubMedPubMedCentralCrossRef Shah SJ, Kitzman DW, Borlaug BA, et al. Phenotype-specific treatment of heart failure with preserved ejection fraction: a multiorgan roadmap. Circulation. 2016;134(1):73–90.PubMedPubMedCentralCrossRef
34.
go back to reference Mohammed SF, Majure DT, Redfield MM. Zooming in on the microvasculature in heart failure with preserved ejection fraction. Circ Heart Fail. 2016:9(7). Mohammed SF, Majure DT, Redfield MM. Zooming in on the microvasculature in heart failure with preserved ejection fraction. Circ Heart Fail. 2016:9(7).
35.
go back to reference Lee MKS, Yvan-Charvet L, Masters SL, et al. The modern interleukin-1 superfamily: divergent roles in obesity. Semin Immunol. 2016;28(5):441–9.PubMedCrossRef Lee MKS, Yvan-Charvet L, Masters SL, et al. The modern interleukin-1 superfamily: divergent roles in obesity. Semin Immunol. 2016;28(5):441–9.PubMedCrossRef
36.
go back to reference Ballak DB, Stienstra R, Tack CJ, et al. IL-1 family members in the pathogenesis and treatment of metabolic disease: focus on adipose tissue inflammation and insulin resistance. Cytokine. 2015;75(2):280–90.PubMedPubMedCentralCrossRef Ballak DB, Stienstra R, Tack CJ, et al. IL-1 family members in the pathogenesis and treatment of metabolic disease: focus on adipose tissue inflammation and insulin resistance. Cytokine. 2015;75(2):280–90.PubMedPubMedCentralCrossRef
37.
go back to reference Murase T, Hattori T, Ohtake M, et al. Cardiac remodeling and diastolic dysfunction in DahlS.Z-Lepr(fa)/Lepr(fa) rats: a new animal model of metabolic syndrome. Hypertens Res. 2012;35(2):186–93.PubMedCrossRef Murase T, Hattori T, Ohtake M, et al. Cardiac remodeling and diastolic dysfunction in DahlS.Z-Lepr(fa)/Lepr(fa) rats: a new animal model of metabolic syndrome. Hypertens Res. 2012;35(2):186–93.PubMedCrossRef
38.
go back to reference Iliodromiti S, Celis-Morales CA, Lyall DM, et al. The impact of confounding on the associations of different adiposity measures with the incidence of cardiovascular disease: a cohort study of 296 535 adults of white European descent. Eur Heart J. 2018;39(17):1514–20.PubMedPubMedCentralCrossRef Iliodromiti S, Celis-Morales CA, Lyall DM, et al. The impact of confounding on the associations of different adiposity measures with the incidence of cardiovascular disease: a cohort study of 296 535 adults of white European descent. Eur Heart J. 2018;39(17):1514–20.PubMedPubMedCentralCrossRef
39.
go back to reference Browning LM, Hsieh SD, Ashwell M. A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0·5 could be a suitable global boundary value. Nutr Res Rev. 2010;23(2):247–69.PubMedCrossRef Browning LM, Hsieh SD, Ashwell M. A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0·5 could be a suitable global boundary value. Nutr Res Rev. 2010;23(2):247–69.PubMedCrossRef
40.
go back to reference Ashwell M, Hsieh SD. Six reasons why the waist-to-height ratio is a rapid and effective global indicator for health risks of obesity and how its use could simplify the international public health message on obesity. Int J Food Sci Nutr. 2005;56(5):303–7.PubMedCrossRef Ashwell M, Hsieh SD. Six reasons why the waist-to-height ratio is a rapid and effective global indicator for health risks of obesity and how its use could simplify the international public health message on obesity. Int J Food Sci Nutr. 2005;56(5):303–7.PubMedCrossRef
41.
go back to reference Liancheng Z, Ying L, Yaguang P, et al. The cut-off value of waist-to-height ratio in detecting central obesity in Chinese adult population. Chin Prevent Med. 2012;07:7–11.CrossRef Liancheng Z, Ying L, Yaguang P, et al. The cut-off value of waist-to-height ratio in detecting central obesity in Chinese adult population. Chin Prevent Med. 2012;07:7–11.CrossRef
42.
go back to reference Myint PK, Kwok CS, Luben RN, et al. Body fat percentage, body mass index and waist-to-hip ratio as predictors of mortality and cardiovascular disease. Heart. 2014;100(20):1613–9.PubMedCrossRef Myint PK, Kwok CS, Luben RN, et al. Body fat percentage, body mass index and waist-to-hip ratio as predictors of mortality and cardiovascular disease. Heart. 2014;100(20):1613–9.PubMedCrossRef
43.
go back to reference Streng KW, Voors AA, Hillege HL, et al. Waist-to-hip ratio and mortality in heart failure. Eur J Heart Fail. 2018;20(9):1269–77.PubMedCrossRef Streng KW, Voors AA, Hillege HL, et al. Waist-to-hip ratio and mortality in heart failure. Eur J Heart Fail. 2018;20(9):1269–77.PubMedCrossRef
44.
go back to reference ChandramouliI C, Tay WT, Bamadhaj NS, et al. Association of obesity with heart failure outcomes in 11 Asian regions: a cohort study. PLoS Med. 2019;16(9):e1002916.CrossRef ChandramouliI C, Tay WT, Bamadhaj NS, et al. Association of obesity with heart failure outcomes in 11 Asian regions: a cohort study. PLoS Med. 2019;16(9):e1002916.CrossRef
45.
go back to reference Kitzman DW, Brubaker P, Morgan T, et al. Effect of caloric restriction or aerobic exercise training on peak oxygen consumption and quality of life in obese older patients with heart failure with preserved ejection fraction: a randomized clinical trial. JAMA. 2016;315(1):36–46.PubMedPubMedCentralCrossRef Kitzman DW, Brubaker P, Morgan T, et al. Effect of caloric restriction or aerobic exercise training on peak oxygen consumption and quality of life in obese older patients with heart failure with preserved ejection fraction: a randomized clinical trial. JAMA. 2016;315(1):36–46.PubMedPubMedCentralCrossRef
46.
go back to reference Collaboration GBM, Angelantonio ED, Bhupathiraju S, et al. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet. 2016;388(10046):776–86.CrossRef Collaboration GBM, Angelantonio ED, Bhupathiraju S, et al. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet. 2016;388(10046):776–86.CrossRef
47.
go back to reference Wormser D, Kaptoge S, Angelantonio ED, et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet. 2011;377(9771):1085–95.PubMedCrossRef Wormser D, Kaptoge S, Angelantonio ED, et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet. 2011;377(9771):1085–95.PubMedCrossRef
Metadata
Title
Waist to height ratio is associated with an increased risk of mortality in Chinese patients with heart failure with preserved ejection fraction
Authors
Jianqiao Chen
Man Li
Benchuan Hao
Yulun Cai
Huiying Li
Wenli Zhou
Yujian Song
Shiqi Wang
Hongbin Liu
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2021
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-021-02080-9

Other articles of this Issue 1/2021

BMC Cardiovascular Disorders 1/2021 Go to the issue